You have 9 free searches left this month | for more free features.

regional pheochromocytoma

Showing 1 - 25 of 3,272

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma Trial in Houston

Recruiting
  • Locally Advanced Paraganglioma
  • +5 more
  • Cabozantinib S-malate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 7, 2021

Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in United

Recruiting
  • Advanced Adrenal Gland Pheochromocytoma
  • +5 more
  • Anchorage, Alaska
  • +153 more
Aug 23, 2022

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Intraoperative Hemodynamic Instability During Unilateral

Recruiting
  • Pheochromocytoma
  • Non-Secretory Adrenal Adenoma
  • adrenalectomy
  • Nancy, France
    CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Can
Sep 25, 2023

Pheochromocytoma Trial in Seoul (dexmedetomidine, 0.9% normal saline)

Completed
  • Pheochromocytoma
  • Seoul, Korea, Republic of
    Severance hospital
Sep 12, 2023

Adrenal Pheochromocytoma, Hemodynamic Trial (Abandonment of intravenous volume expansion during preoperative preparation in

Completed
  • Adrenal Pheochromocytoma
  • Hemodynamic
  • Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
  • (no location specified)
Mar 25, 2023

Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child

Recruiting
  • Pheochromocytoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2023

Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

I Hemodynamic Instability and Conversion in Adrenalectomy for

Completed
  • adrenalDisease
  • laparoscopic adrenalectomy
  • (no location specified)
Sep 26, 2023

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

Recruiting
  • Paraganglioma
  • Pheochromocytoma
  • New York, New York
  • +1 more
Oct 5, 2022

Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)

Recruiting
  • Pheochromocytoma
  • +7 more
  • Genetic screening
  • San Antonio, Texas
    University of Texas Health Science Center
Aug 25, 2022

Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Genetic Factors and Pheochromocytomas in Neoplasia Type 2

Recruiting
  • Neoplasia
  • Pheochromocytoma
    • Marseille, France
      APHM - Hôpital de la Conception
    Jan 30, 2022

    Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

    Recruiting
    • Pheochromocytoma, Metastatic
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    May 31, 2023

    Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

    Not yet recruiting
    • Pheochromocytoma
    • Paraganglioma
    • [18F]FluorThanatrace ([18F]FTT)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Dec 1, 2022

    Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

    Completed
    • Malignant Adrenal Gland Pheochromocytoma
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 28, 2022

    Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)

    Completed
    • Pheochromocytoma, Metastatic
    • +2 more
    • Temozolomide capsule
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 4, 2023

    Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)

    Recruiting
    • Pheochromocytoma/Paraganglioma
    • +2 more
    • Los Angeles, California
    • +58 more
    Jan 27, 2023

    Magnesium and Dexmedetomidine in Pheochromocytoma

    Completed
    • Phaeochromocytoma Crisis
    • Hemodynamic Instability
    • (no location specified)
    Oct 20, 2021

    PGL Trial in Beijing

    Recruiting
    • PGL
      • Beijing, Beijing, China
        Peking Union Medical College Hospital,Chinese Academy of Medical
      Mar 6, 2023

      Neuroblastoma, Pheochromocytoma Trial in Memphis (18F-DA)

      Recruiting
      • Neuroblastoma
      • Pheochromocytoma
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 15, 2022